Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-29

Clinical Trial Update: The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the use of Botulinum toxin type A in two-stage tissue expander/implant breast reconstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University of British Columbia | Conditions: Breast Neoplasms, Neoplasms by Site | Phase 4 | Status: UNKNOWN